Eptifibatide Patent Expiration
Eptifibatide is Used for preventing blood clot formation in patients with platelet-associated ischemic disorders. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Eptifibatide Patents
Given below is the list of patents protecting Eptifibatide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Integrilin | US5807825 | Platelet aggregation inhibitors |
Sep 15, 2015
(Expired) | Msd Sub Merck |
| Integrilin | US5968902 | Platelet aggregation inhibitors |
Jun 02, 2015
(Expired) | Msd Sub Merck |
| Integrilin | US5747447 | Stable polypeptide composition |
May 05, 2015
(Expired) | Msd Sub Merck |
| Integrilin | US5686570 | Platelet aggregation inhibitors |
Nov 11, 2014
(Expired) | Msd Sub Merck |
| Integrilin | US5756451 | Platelet aggregation inhibitors |
Nov 11, 2014
(Expired) | Msd Sub Merck |
Eptifibatide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List